These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9748708)

  • 61. Effects of clonidine on biochemical indices of sympathetic function and plasma renin activity in normotensive man.
    Wing LM; Reid JL; Hamilton CA; Sever P; Davies DS; Dollery CT
    Clin Sci Mol Med; 1977 Jul; 53(1):45-53. PubMed ID: 872520
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral eperisone.
    Yang SI; Park HY; Lee SH; Lee SJ; Han OY; Lim SC; Jang CG; Lee WS; Shin YH; Kim JJ; Lee SY
    Pharmacology; 2004 Jul; 71(3):150-6. PubMed ID: 15161997
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Transdermal clonidine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Langley MS; Heel RC
    Drugs; 1988 Feb; 35(2):123-42. PubMed ID: 3281820
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evidence for a central alpha-sympathomimetic action of clonidine in the rat.
    Finch L; Buckingham RE; Moore RA; Bucher TJ
    J Pharm Pharmacol; 1975 Mar; 27(3):181-6. PubMed ID: 238001
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sympathoinhibitory response to clonidine is blunted in patients with heart failure.
    Lang CC; Stein CM; Nelson RA; He HB; Belas FJ; Blair IA; Wood M; Wood AJ
    Hypertension; 1997 Sep; 30(3 Pt 1):392-7. PubMed ID: 9314422
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rebound hypertension during initiation of transdermal clonidine.
    Stewart M; Burris JF
    Drug Intell Clin Pharm; 1988; 22(7-8):573-4. PubMed ID: 3416742
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of clonidine on the thermic effect of feeding in humans.
    Schwartz RS; Jaeger LF; Veith RC
    Am J Physiol; 1988 Jan; 254(1 Pt 2):R90-4. PubMed ID: 3337274
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Plasma dilution during transdermal clonidine antihypertensive monotherapy.
    Zawada ET; Jensen RA; Williams L; Zeigler DW; Kauker ML
    Int J Artif Organs; 1989 Mar; 12(3):200-3. PubMed ID: 2744881
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical pharmacokinetics of clonidine.
    Lowenthal DT; Matzek KM; MacGregor TR
    Clin Pharmacokinet; 1988 May; 14(5):287-310. PubMed ID: 3293868
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transdermal antihypertensive therapy: clinical and metabolic considerations.
    Weber MA
    Am Heart J; 1986 Oct; 112(4):906-12. PubMed ID: 2945415
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hemodynamic and metabolic effects of transdermal clonidine in patients with hypertension and non-insulin-dependent diabetes mellitus.
    Giugliano D; Acampora R; Marfella R; La Marca C; Marfella M; Nappo F; D'Onofrio F
    Am J Hypertens; 1998 Feb; 11(2):184-9. PubMed ID: 9524046
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy of transdermal clonidine in short-term treatment of cluster headache: a pilot study.
    D'Andrea G; Perini F; Granella F; Cananzi A; Sergi A
    Cephalalgia; 1995 Oct; 15(5):430-3. PubMed ID: 8536305
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Determination of norepinephrine in small volume plasma samples by stable-isotope dilution gas chromatography-tandem mass spectrometry with negative ion chemical ionization.
    Kuhlenbeck DL; O'Neill TP; Mack CE; Hoke SH; Wehmeyer KR
    J Chromatogr B Biomed Sci Appl; 2000 Feb; 738(2):319-30. PubMed ID: 10718650
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sustained elevation of norepinephrine depresses hepatocellular function.
    Wang P; Tait SM; Chaudry IH
    Biochim Biophys Acta; 2000 Dec; 1535(1):36-44. PubMed ID: 11113629
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Utility of a transdermal delivery system for antihypertensive therapy. Part 1.
    Sclar DA; Skaer TL; Chin A; Okamoto MP; Gill MA
    Am J Med; 1991 Jul; 91(1A):50S-56S. PubMed ID: 1907801
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The USA experience with the clonidine transdermal therapeutic system.
    Burris JF
    Clin Auton Res; 1993 Dec; 3(6):391-6. PubMed ID: 8193527
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Pharmacological study of para-aminoclonidine, an alpha sympathomimetic].
    Rouot B; Leclerc G; Bieth N; Wermuth CG; Schwartz J
    C R Acad Hebd Seances Acad Sci D; 1978 Mar; 286(11):909-12. PubMed ID: 27313
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route.
    Shaw JE
    Am Heart J; 1984 Jul; 108(1):217-23. PubMed ID: 6428208
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Oral substitution in patients sensitized by transdermal clonidine treatment.
    Maibach HI
    Contact Dermatitis; 1987 Jan; 16(1):1-8. PubMed ID: 3816202
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Reduction of anxiety after treatment with transdermal clonidine.
    Ye L; Lippmann S
    Am J Health Syst Pharm; 2018 Jun; 75(11):742-744. PubMed ID: 29802109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.